Exome sequencing reveals germline gain-of-function EGFR mutation in an adult with Lhermitte-Duclos disease

被引:13
作者
Colby, Samantha [1 ,2 ,3 ]
Yehia, Lamis [1 ,2 ,4 ]
Niazi, Farshad [1 ,2 ]
Chen, JinLian [1 ,2 ]
Ni, Ying [1 ,2 ]
Mester, Jessica L. [1 ,2 ]
Eng, Charis [1 ,2 ,5 ,6 ,7 ,8 ]
机构
[1] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH 44195 USA
[4] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA
[5] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA
[6] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA
[7] Case Western Reserve Univ, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA
[8] Case Western Reserve Univ, CASE Comprehens Canc Ctr, Germline High Risk Focus Grp, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
neoplasm of the nervous system;
D O I
10.1101/mcs.a001230
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lhermitte-Duclos disease (LDD) is a rare cerebellar disorder believed to be pathognomonic for Cowden syndrome. Presently, the only known etiology is germline PTEN mutation. We report a 41-yr-old white female diagnosed with LDD and wild-type for PTEN. Exome sequencing revealed a germline heterozygous EGFR mutation that breaks a disulfide bond in the receptor's extracellular domain, resulting in constitutive activation. Functional studies demonstrate activation of ERK/AKT signaling pathways, mimicking PTEN loss-of-function downstream effects. The identification of EGFR as a candidate LDD susceptibility gene contributes to advancement of molecular diagnosis and targeted therapy for this rare condition with limited treatment options.
引用
收藏
页数:14
相关论文
共 45 条
[1]   Somatic mutations of EGFR in colorectal cancers and glioblastomas [J].
Barber, TD ;
Vogelstein, B ;
Kinzler, KW ;
Velculescu, VE .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2883-2883
[2]   Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR [J].
Bell, DW ;
Gore, I ;
Okimoto, RA ;
Godin-Heymann, N ;
Sordella, R ;
Mulloy, R ;
Sharma, SV ;
Brannigan, BW ;
Mohapatra, G ;
Settleman, J ;
Haber, DA .
NATURE GENETICS, 2005, 37 (12) :1315-1316
[3]   Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-like Syndrome [J].
Bennett, Kristi L. ;
Mester, Jessica ;
Eng, Charis .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (24) :2724-2731
[4]   Check your cultures! A list of cross-contaminated or misidentified cell lines [J].
Capes-Davis, Amanda ;
Theodosopoulos, George ;
Atkin, Isobel ;
Drexler, Hans G. ;
Kohara, Arihiro ;
MacLeod, Roderick A. F. ;
Masters, John R. ;
Nakamura, Yukio ;
Reid, Yvonne A. ;
Reddel, Roger R. ;
Freshney, R. Ian .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (01) :1-8
[5]   Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib [J].
Carey, Kendall D. ;
Garton, Andrew J. ;
Romero, Maria S. ;
Kahler, Jennifer ;
Thomson, Stuart ;
Ross, Sarajane ;
Park, Frances ;
Haley, John D. ;
Gibson, Neil ;
Sliwkowski, Mark X. .
CANCER RESEARCH, 2006, 66 (16) :8163-8171
[6]   Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera [J].
Carter, RE ;
Sorkin, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :35000-35007
[7]   Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: A novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma [J].
Centeno, Irene ;
Blay, Pilar ;
Santamaria, Inigo ;
Astudillo, Aurora ;
Pitiot, Ana S. ;
Osorio, Fernando G. ;
Gonzalez-Arriaga, Patricia ;
Iglesias, Fernando ;
Menendez, Primitiva ;
Tardon, Adonina ;
Freije, Jose M. ;
Balbin, Milagros .
BMC CANCER, 2011, 11
[8]   Drug therapy: EGFR antagonists in cancer treatment [J].
Ciardiello, Fortunato ;
Tortora, Giampaolo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) :1160-1174
[9]   PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies [J].
Dahia, PLM ;
Aguiar, RCT ;
Alberta, J ;
Kum, JB ;
Caron, S ;
Sill, H ;
Marsh, DJ ;
Ritz, J ;
Freedman, A ;
Stiles, C ;
Eng, C .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :185-193
[10]  
Fromer Menachem, 2014, Curr Protoc Hum Genet, V81, DOI 10.1002/0471142905.hg0723s81